Mortality from liver cancer after the licensure of lifesaving drugs for hepatitis C virus in the U.S. (IMAGE)

Florida Atlantic University

Mortality from liver cancer after the licensure of lifesaving drugs for hepatitis C virus in the U.S.

Caption

Charles H. Hennekens, M.D., Dr.PH, senior author, and the first Sir Richard Doll Professor and senior academic advisor in FAU's Schmidt College of Medicine, and an adjunct professor at Baylor College of Medicine.

Credit

Alex Dolce, Florida Atlantic University

Usage Restrictions

Credit: Alex Dolce, Florida Atlantic University

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.